Works matching IS 10837159 AND DT 2020 AND VI 25 AND IP 8

Results: 30
    1

    ALK‐Rearranged Non‐Small Cell Lung Cancer in 2020: Real‐World Triumphs in an Era of Multigeneration ALK‐Inhibitor Sequencing Informed by Drug Resistance Profiling.

    Published in:
    Oncologist, 2020, v. 25, n. 8, p. 641, doi. 10.1634/theoncologist.2020-0075
    By:
    • Itchins, Malinda;
    • Lau, Brandon;
    • Hudson, Amanda L.;
    • Westman, Helen;
    • Xia, Cathy Yi;
    • Hayes, Sarah A.;
    • Howell, Viive M.;
    • Rodriguez, Michael;
    • Cooper, Wendy A.;
    • Wei, Heng;
    • Buckland, Michael;
    • Li, Bob T.;
    • Li, Mark;
    • Rathi, Vivek;
    • Fox, Stephen B.;
    • Gill, Anthony J.;
    • Clarke, Stephen J.;
    • Boyer, Michael J.;
    • Pavlakis, Nick
    Publication type:
    Article
    2
    3
    4

    Safety and Feasibility of Additional Tumor Debulking to First‐Line Palliative Combination Chemotherapy for Patients with Multiorgan Metastatic Colorectal Cancer.

    Published in:
    Oncologist, 2020, v. 25, n. 8, p. e1195, doi. 10.1634/theoncologist.2019-0693
    By:
    • Gootjes, Elske C.;
    • Stok, Eric P.;
    • Buffart, Tineke E.;
    • Bakkerus, Lotte;
    • Labots, Mariette;
    • Zonderhuis, Barbara M.;
    • Tuynman, Jurriaan B.;
    • Meijerink, Martijn R.;
    • Ven, Peter M.;
    • Haasbeek, Cornelis J.A.;
    • ten Tije, Albert J.;
    • Groot, Jan‐Willem B.;
    • Hendriks, Mathijs P.;
    • Meerten, Esther;
    • Nuyttens, Joost J.M.E.;
    • Grunhagen, Dirk J.;
    • Verhoef, Cornelis;
    • Verheul, Henk M.W.
    Publication type:
    Article
    5
    6
    7
    8

    Phase I Study of Veliparib on an Intermittent and Continuous Schedule in Combination with Carboplatin in Metastatic Breast Cancer: A Safety and [18F]‐Fluorothymidine Positron Emission Tomography Biomarker Study.

    Published in:
    Oncologist, 2020, v. 25, n. 8, p. e1158, doi. 10.1634/theoncologist.2020-0039
    By:
    • Wesolowski, Robert;
    • Stover, Daniel G.;
    • Lustberg, Maryam B.;
    • Shoben, Abigail;
    • Zhao, Meng;
    • Mrozek, Ewa;
    • Layman, Rachel M.;
    • Macrae, Erin;
    • Duan, Wenrui;
    • Zhang, Jun;
    • Hall, Nathan;
    • Wright, Chadwick L.;
    • Gillespie, Susan;
    • Berger, Michael;
    • Chalmers, Jeffrey J.;
    • Carey, Alahdra;
    • Balasubramanian, Priya;
    • Miller, Brandon L.;
    • Amaya, Peter;
    • Andreopoulou, Eleni
    Publication type:
    Article
    9
    10
    11

    In Reply.

    Published in:
    Oncologist, 2020, v. 25, n. 8, p. e1259, doi. 10.1634/theoncologist.2020-0336
    By:
    • Grande, Enrique;
    • Molina‐Cerrillo, Javier;
    • Alonso‐Gordoa, Teresa
    Publication type:
    Article
    12
    13
    14

    In Reply.

    Published in:
    Oncologist, 2020, v. 25, n. 8, p. e1255, doi. 10.1634/theoncologist.2020-0119
    By:
    • Raber, Inbar;
    • Peters, Mary Linton;
    • Asnani, Aarti
    Publication type:
    Article
    15
    16
    17

    Randomized Phase II Study of First‐Line Biweekly Gemcitabine and Carboplatin Versus Biweekly Gemcitabine and Carboplatin plus Maintenance Gemcitabine in Elderly Patients with Untreated Non‐Small Cell Lung Cancer: LOGIK0801.

    Published in:
    Oncologist, 2020, v. 25, n. 8, p. e1146, doi. 10.1634/theoncologist.2020-0322
    By:
    • Takayama, Koichi;
    • Takeshita, Masafumi;
    • Inoue, Koji;
    • Ichiki, Masao;
    • Fujita, Masaki;
    • Harada, Taishi;
    • Shiraishi, Yoshimasa;
    • Wataya, Hiroshi;
    • Tokunaga, Shoji;
    • Yamada, Tadaaki;
    • Uchino, Junji;
    • Sugio, Kenji
    Publication type:
    Article
    18
    19

    Statin Intolerance, Anti‐HMGCR Antibodies, and Immune Checkpoint Inhibitor‐Associated Myositis: A "Two‐Hit" Autoimmune Toxicity or Clinical Predisposition?

    Published in:
    Oncologist, 2020, v. 25, n. 8, p. e1242, doi. 10.1634/theoncologist.2019-0911
    By:
    • von Itzstein, Mitchell S.;
    • Khan, Shaheen;
    • Popat, Vinita;
    • Lu, Rong;
    • Khan, Saad A.;
    • Fattah, Farjana J.;
    • Park, Jason Y.;
    • Bermas, Bonnie L.;
    • Karp, David R.;
    • Ahmed, Murtaza;
    • Saltarski, Jessica M.;
    • Gloria‐McCutchen, Yvonne;
    • Xie, Yang;
    • Li, Quan‐Zhen;
    • Wakeland, Edward K.;
    • Gerber, David E.
    Publication type:
    Article
    20
    21

    Association of Programmed Death‐Ligand 1 Expression with Fusion Variants and Clinical Outcomes in Patients with Anaplastic Lymphoma Kinase‐Positive Lung Adenocarcinoma Receiving Crizotinib.

    Published in:
    Oncologist, 2020, v. 25, n. 8, p. 702, doi. 10.1634/theoncologist.2020-0088
    By:
    • Yang, Ching‐Yao;
    • Liao, Wei‐Yu;
    • Ho, Chao‐Chi;
    • Chen, Kuan‐Yu;
    • Tsai, Tzu‐Hsiu;
    • Hsu, Chia‐Lin;
    • Liu, Yi‐Nan;
    • Su, Kang‐Yi;
    • Chang, Yih‐Leong;
    • Wu, Chen‐Tu;
    • Liao, Bin‐Chi;
    • Hsu, Chia‐Chi;
    • Hsu, Wei‐Hsun;
    • Lee, Jih‐Hsiang;
    • Lin, Chia‐Chi;
    • Shih, Jin‐Yuan;
    • Yang, James Chih‐Hsin;
    • Yu, Chong‐Jen
    Publication type:
    Article
    22

    In Reply.

    Published in:
    Oncologist, 2020, v. 25, n. 8, p. e1252, doi. 10.1634/theoncologist.2020-0329
    By:
    • Coomes, Eric A.;
    • Al‐Shamsi, Humaid O.;
    • Meyers, Brandon M.;
    • Alhazzani, Waleed;
    • Alhuraiji, Ahmad;
    • Chemaly, Roy F.;
    • Almuhanna, Meshari;
    • Wolff, Robert A.;
    • Ibrahim, Nuhad K.;
    • Chua, Melvin L.K.;
    • Hotte, Sebastien J.;
    • Elfiki, Tarek;
    • Curigliano, Giuseppe;
    • Eng, Cathy;
    • Grothey, Axel;
    • Xie, Conghua
    Publication type:
    Article
    23
    24
    25
    26
    27

    Cardiovascular Outcomes in Relation to Antihypertensive Medication Use in Women with and Without Cancer: Results from the Women's Health Initiative.

    Published in:
    Oncologist, 2020, v. 25, n. 8, p. 712, doi. 10.1634/theoncologist.2019-0977
    By:
    • Reding, Kerryn W.;
    • Aragaki, Aaron K.;
    • Cheng, Richard K.;
    • Barac, Ana;
    • Wassertheil‐Smoller, Sylvia;
    • Chubak, Jessica;
    • Limacher, Marian C.;
    • Hundley, W. Gregory;
    • D'Agostino, Ralph;
    • Vitolins, Mara Z.;
    • Brasky, Theodore M.;
    • Habel, Laurel A.;
    • Chow, Eric J.;
    • Jackson, Rebecca D.;
    • Chen, Chu;
    • Morgenroth, April;
    • Barrington, Wendy E.;
    • Banegas, Matthew;
    • Barnhart, Matthew;
    • Chlebowski, Rowan T.
    Publication type:
    Article
    28

    The MIMIC Study: Prognostic Role and Cutoff Definition of Monocyte‐to‐Lymphocyte Ratio and Lactate Dehydrogenase Levels in Metastatic Colorectal Cancer.

    Published in:
    Oncologist, 2020, v. 25, n. 8, p. 661, doi. 10.1634/theoncologist.2019-0780
    By:
    • Basile, Debora;
    • Garattini, Silvio Ken;
    • Corvaja, Carla;
    • Montico, Marcella;
    • Cortiula, Francesco;
    • Pelizzari, Giacomo;
    • Gerratana, Lorenzo;
    • Audisio, Marco;
    • Lisanti, Camilla;
    • Fanotto, Valentina;
    • Ongaro, Elena;
    • Iacono, Donatella;
    • Cardellino, Giovanni Gerardo;
    • Foltran, Luisa;
    • Pella, Nicoletta;
    • Buonadonna, Angela;
    • Aprile, Giuseppe;
    • Di Maio, Massimo;
    • Fasola, Gianpiero;
    • Puglisi, Fabio
    Publication type:
    Article
    29
    30

    Immune‐Related Adverse Events and Immune Checkpoint Inhibitor Efficacy in Patients with Gastrointestinal Cancer with Food and Drug Administration‐Approved Indications for Immunotherapy.

    Published in:
    Oncologist, 2020, v. 25, n. 8, p. 669, doi. 10.1634/theoncologist.2019-0637
    By:
    • Das, Satya;
    • Ciombor, Kristen K.;
    • Haraldsdottir, Sigurdis;
    • Pumpalova, Yoanna;
    • Sahin, Ibrahim H.;
    • Pineda, G.;
    • Shyr, Yu;
    • Lin, E.P.;
    • Hsu, Chih‐Yuan;
    • Chu, Shih‐Kai;
    • Goff, Laura W.;
    • Cardin, Dana B.;
    • Bilen, Mehmet A.;
    • Fisher, George A.;
    • Wu, Christina;
    • Berlin, Jordan
    Publication type:
    Article